``Click''-Cyclized ^6^8Ga-Labeled Peptides for Molecular Imaging and Therapy: Synthesis and Preliminary In Vitro and In Vivo Evaluation in a Melanoma Model System (English)
- New search for: Baum, Richard P.
- New search for: Rosch, Frank
In:
Theranostics, Gallium-68, and other radionuclides: a pathway to personalized diagnosis and treatment /
;
149-176
;
2013
-
ISBN:
-
ISSN:
- Conference paper / Print
-
Title:``Click''-Cyclized ^6^8Ga-Labeled Peptides for Molecular Imaging and Therapy: Synthesis and Preliminary In Vitro and In Vivo Evaluation in a Melanoma Model System
-
Contributors:
-
Conference:World congress; 1st, Theranostics, Gallium-68, and other radionuclides: a pathway to personalized diagnosis and treatment / ; 2011 ; Bad Berka, Germany
-
Published in:RECENT RESULTS IN CANCER RESEARCH ; 194 ; 149-176
-
Publisher:
- New search for: Springer
-
Place of publication:Heidelberg
-
Publication date:2013-01-01
-
Size:28 pages
-
Remarks:Based on those presented at the conference. Includes bibliographical references. Also published electronically.
-
ISBN:
-
ISSN:
-
Type of media:Conference paper
-
Type of material:Print
-
Language:English
-
Keywords:
-
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents conference proceedings
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 3
-
^6^8Ge/^6^8Ga Generators: Past, Present, and Future| 2013
- 17
-
Overview and Perspectives on Automation Strategies in ^6^8Ga Radiopharmaceutical Preparations| 2013
- 33
-
Post-Processing via Cation Exchange Cartridges: Versatile Options| 2013
- 43
-
^6^8Ga Generator Integrated System: Elution-Purification-Concentration Integration| 2013
- 77
-
Purification and Labeling Strategies for ^6^8Ga from ^6^8Ge/^6^8Ga Generator Eluate| 2013
- 89
-
^6^7Ga and ^6^8Ga Purification Studies: Preliminary Results| 2013
- 101
-
The Diversity of ^6^8Ga-Based Imaging Agents| 2013
- 133
-
Nanoparticles and Phage Display Selected Peptides for Imaging and Therapy of Cancer| 2013
- 149
-
``Click''-Cyclized ^6^8Ga-Labeled Peptides for Molecular Imaging and Therapy: Synthesis and Preliminary In Vitro and In Vivo Evaluation in a Melanoma Model System| 2013
- 177
-
Early Experience with ^6^8Ga-DOTATATE Preparation| 2013
- 189
-
^6^8Ga-Radiopharmaceuticals for PET Imaging of Infection and Inflammation| 2013
- 221
-
^6^8Ga-Labeled Bombesin Analogs for Receptor-Mediated Imaging| 2013
- 257
-
A Novel ^6^8Ga-Labeled Pteroic Acid-Based PET Tracer for Tumor Imaging via the Folate Receptor| 2013
- 269
-
Measurement of Protein Synthesis: In Vitro Comparison of ^6^8Ga-DOTA-Puromycin, [^3H]Tyrosine, and 2-Fluoro-[^3H]tyrosine| 2013
- 285
-
Hypoxia Imaging Agents Labeled with Positron Emitters| 2013
- 321
-
Divergent Role of ^6^8Ga-Labeled Somatostatin Analogs in the Workup of Patients with NETs: AIIMS Experience| 2013
- 353
-
Differential Uptake of ^6^8Ga-DOTATOC and ^6^8Ga-DOTATATE in PET/CT of Gastroenteropancreatic Neuroendocrine Tumors| 2013
- 373
-
High Uptake of ^6^8Ga-DOTATOC in Spleen as Compared to Splenosis: Measurement by PET/CT| 2013
- 379
-
Rare Metastases Detected by ^6^8Ga-Somatostatin Receptor PET/CT in Patients with Neuroendocrine Tumors| 2013
- 385
-
Comparison of Different Positron Emission Tomography Tracers in Patients with Recurrent Medullary Thyroid Carcinoma: Our Experience and a Review of the Literature| 2013
- 395
-
PET Lung Ventilation/Perfusion Imaging Using ^6^8Ga Aerosol (Galligas) and ^6^8Ga-Labeled Macroaggregated Albumin| 2013
- 425
-
Combined PET/MR Imaging Using ^6^8Ga-DOTATOC for Radiotherapy Treatment Planning in Meningioma Patients| 2013
- 443
-
A Rare Case of a Large Spinal Meningioma with Mediastinal Extension and Malignant Behavior Classified Histologically as Benign| 2013
- 457
-
Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors in Germany: First Results of a Multi-institutional Cancer Registry| 2013
- 467
-
Polish Experience in Peptide Receptor Radionuclide Therapy| 2013
- 479
-
PRRT as Neoadjuvant Treatment in NET| 2013
- 487
-
Intraoperative Somatostatin Receptor Detection After Peptide Receptor Radionuclide Therapy with ^1^7^7Lu- and ^9^0Y-DOTATOC (Tandem PRRNT) in a Patient with a Metastatic Neuroendocrine Tumor| 2013
- 497
-
Personalized Image-Based Radiation Dosimetry for Routine Clinical Use in Peptide Receptor Radionuclide Therapy: Pretherapy Experience| 2013
- 519
-
The Bad Berka Dose Protocol: Comparative Results of Dosimetry in Peptide Receptor Radionuclide Therapy Using ^1^7^7Lu-DOTATATE, ^1^7^7Lu-DOTANOC, and ^1^7^7Lu-DOTATOC| 2013
- 537
-
4D SPECT/CT Acquisition for 3D Dose Calculation and Dose Planning in ^1^7^7Lu-Peptide Receptor Radionuclide Therapy: Applications for Clinical Routine| 2013
- 551
-
Peptide Receptor Radionuclide Therapy with ^1^7^7Lu Labeled Somatostatin Analogs DOTATATE and DOTATOC: Contrasting Renal Dosimetry in the Same Patient| 2013
- 561
-
Is There a Correlation Between Peptide Receptor Radionuclide Therapy-Associated Hematological Toxicity and Spleen Dose?| 2013
- 567
-
Old and New Peptide Receptor Targets in Cancer: Future Directions| 2013